Industry Newsrevenue modelsadsopenaidrug discovery
OpenAI CFO Proposes Licensing Models For Revenue
7.2
Relevance ScoreOpenAI CFO Sarah Friar said on the OpenAI Podcast on Monday the company is exploring "licensing models" that would let it take a share of downstream sales if customers' products succeed, citing drug-discovery examples. Her remarks come as OpenAI prepares to test ads (announced last week), faces roughly $1.4 trillion in spending commitments, and completed an October restructuring toward a for-profit model.



